Skip to main content
U.S. flag

An official website of the United States government

Behavioral and Social Research Funding Opportunities and Applicant Resources

Time-Limited Funding Opportunities

Time-limited FOAs typically have a single due date and a special allocation of funds. BSR is accepting grant applications to a number of time-limited funding opportunities in different scientific domains related to aging, AD/ADRD, and COVID-19 research. Please see below for current time-limited funding opportunities.

FOA Number Title Focus Release Date Final Due Date
RFA-AG-23-034

Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Required)

NIA intends to commit $1.4 million in fiscal year 2023 to fund 2-4 awards.

AD/ADRD 10/3/2022 1/20/2023
RFA-AG-23-018

Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed)

NIA intends to commit $16,200,000 in FY 2023 to fund 1 award.

AD/ADRD

9/2/2022 2/3/2023

BSR Opportunities in AD/ADRD

Parent Funding Opportunities and Associated NOSIs

NIA has two parent funding opportunities that invite applications on a variety of Alzheimer’s disease and Alzheimer's disease related dementias research topics. PAR-22-093 is for R01 applications and PAR-22-094 is for R21 applications. Notices of Special Interest associated with these parent FOAs specify high priority behavioral and social research topics and are listed below.

FOA Number

Title

Release Date

Expiration Date

NOT-AG-21-051 Notice of Special Interest (NOSI): Sleep Disorders and Circadian Clock Disruption in Alzheimer's Disease and other Dementias of Aging 1/11/2022 11/13/2024

NOT-AG-21-050

Notice of Special Interest (NOSI): Sex and Gender Differences in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)

1/6/2022

11/13/2024

NOT-AG-21-049

Notice of Special Interest (NOSI): Dementia Care Workforce for Those Living with Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)

1/6/2022

11/13/2024

NOT-AG-21-048

Notice of Special Interest (NOSI): Digital Technology for Early Detection and Monitoring of Alzheimer’s Disease and Related Dementias

1/6/2022

11/13/2024

NOT-AG-21-047

Notice of Special Interest (NOSI): Behavioral and Social Science Priority Areas in Dementia Care Partner/Caregiver Research

1/6/2022

11/13/2024

NOT-AG-21-046

Notice of Special Interest (NOSI): Dementia Care Research: Programs and services for persons with dementia

1/6/2022

11/13/2024

NOT-AG-21-045

Notice of Special Interest (NOSI): Opportunities for Research in Epidemiology of Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) and Cognitive Resilience

1/6/2022

11/13/2024

NOT-AG-21-044 Notice of Special Interest (NOSI): Sensory and Motor System Changes as Predictors of Preclinical Alzheimer's Disease 1/6/2022 11/13/2024
NOT-AG-21-039 Notice of Special Interest: Understanding Alzheimer's Disease in the Context of the Aging Brain 12/30/2021 11/13/2024
NOT-AG-21-036 Notice of Special Interest (NOSI): Novel Approaches to Diagnosing and Studying Clinical Alzheimer's Disease and Related Dementias 1/7/2022 11/13/2024

NOT-AG-21-035

Notice of Special Interest: Collaborative Studies on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD)

12/30/2021

11/13/2024

NOT-AG-21-033

Notice of Special Interest: Health Disparities and Alzheimer's Disease

12/22/2021

11/13/2024

Major Opportunities in AD/ADRD Research

In addition to the parent AD/ADRD funding opportunities, BSR participates in other announcements aimed specifically at building AD/ADRD research infrastructure, developing clinical trials, and more. AD/ADRD research is also included in many other announcements in which BSR participates, detailed in the Current Funding Opportunities section below.

FOA Number Title Release Date Expiration Date
PAR-21-360 Pilot Studies for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) 1/10/2022 1/8/2025
PAR-21-359 Early and Late Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) 1/10/2022 1/8/2025
PAR-22-362 NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional) 1/7/2022 10/2/2024
PAR-22-077 NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional) 12/22/2021 10/18/2024
PAR-21-307

Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required)

8/11/2021 2/14/2024
PAR-21-308 Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 – Clinical Trial Required) 8/11/2021 2/14/2024
PAR-21-220 NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) 5/28/2021 6/13/2024
PAR-21-218 NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31) 5/28/2021 8/9/2024
PAR-21-217 NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) 5/28/2021 8/9/2024
PAR-21-141 AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed) 3/4/2021 9/8/2023
PAR-21-112

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)

1/22/2021 9/26/2023

Current Funding Opportunities

BSR is accepting grant applications to a number of funding opportunities in different scientific domains related to aging, AD/ADRD, and COVID-19 research. Please see below for current funding opportunities.

The full list of NIA-wide active funding opportunities and NIA-wide AD/ADRD funding opportunities can also be found online.

FOA Number Title Focus Release Date Expiration Date
NOT-AG-22-030 Notice of Special Interest (NOSI): Small Research Grants for Innovations in Healthy Longevity Research Aging 9/13/2022 5/8/2023
NOT-OD-22-203

Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions

Aging 9/9/2022 9/27/2024
NOT-OD-22-166

Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People

AD/ADRD

Aging

8/11/2022 5/8/2025
NOT-MD-22-012

Notice of Special Interest (NOSI): Research on the Health of Sexual and Gender Minority (SGM) Populations

AD/ADRD

Aging

7/11/2022 8/8/2025
NOT-OD-22-167 Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes

AD/ADRD

Aging

7/8/2022 10/5/2025
PAR-22-213 Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)

AD/ADRD

Aging

7/7/2022 9/26/2025
NOT-ES-22-006

Notice of Special Interest (NOSI): Climate Change and Health

AD/ADRD

Aging

6/1/2022 5/8/2025
PAR-22-105 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

AD/ADRD

Aging

5/10/2022 5/8/2025
PAR-22-109 Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

AD/ADRD

Aging

5/10/2022 5/8/2025
PAR-22-106 Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

AD/ADRD

Aging

5/9/2022 9/8/2025
RFA-AG-23-016 Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)

AD/ADRD

Aging

4/11/2022 10/19/2024
PAR-22-145 Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)

AD/ADRD

Aging

3/31/2022 5/8/2025
PAR-22-072 Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)

AD/ADRD

Aging

11/22/2021 5/8/2024
PAR-22-060 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

AD/ADRD

Aging

1/10/2022 1/8/2025
NOT-AG-22-004 Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging

AD/ADRD

Aging

12/22/2021 1/8/2025

PAR-21-352

Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required)

AD/ADRD

Aging

10/5/2021 9/8/2024
PAR-21-350 Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)

AD/ADRD

Aging

10/5/2021 6/22/2024
PAR-21-349

Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)

AD/ADRD

Aging

10/5/2021 6/22/2024
NOT-AG-21-020 Notice of Special Interest (NOSI): Maximizing the Scientific Value of Secondary Analyses of Existing Cohorts and Datasets in Order to Address Research Gaps and Foster Additional Opportunities in Aging Research

AD/ADRD

Aging

8/23/2021 9/8/2023
NOT-MH-21-330 Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations COVID-19 8/20/2021 9/8/2024

PAR-21-281

Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed)

AD/ADRD

Aging

7/9/2021 5/8/2023
PAR-21-280 Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)

AD/ADRD

Aging

7/9/2021 5/8/2023
PAR-21-275 The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)

AD/ADRD

Aging

6/25/2021 9/8/2024
PAR-21-154 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)

AD/ADRD

Aging

5/19/2021 5/8/2024
NOT-OD-21-100 Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health

AD/ADRD

Aging

4/8/2021 6/8/2024
NOT-AT-21-002 Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease

AD/ADRD

Aging

1/22/2021 5/7/2024
PAR-21-099 Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional)

AD/ADRD

Aging

12/23/2020 2/17/2023

PAR-21-100

Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional)

AD/ADRD

Aging

12/23/2020 2/06/2023
PAR-21-080 Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)

AD/ADRD

Aging

11/17/2020 1/8/2023
NOT-AG-21-012 Notice of Special Interest: Integrative Studies of Neural Mechanisms Underlying Fundamental Affective Processes in Aging

AD/ADRD

Aging

10/15/2020 1/8/2024
PAR-20-266 Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)

AD/ADRD

Aging

7/15/2020 6/20/2023
PA-20-172 Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)

AD/ADRD

Aging

4/20/2020 9/8/2023
NOT-OD-20-079 Notice of Special Interest (NOSI): Research to Improve the Interpretation of Patient-Reported Outcomes at the Individual Patient Level for Use in Clinical Practice

AD/ADRD

Aging

3/24/2020 5/8/2023
PAR-20-139 Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)

AD/ADRD

Aging

3/13/2020 1/14/2023

nia.nih.gov

An official website of the National Institutes of Health